Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)
Phase 1
Recruiting
- Conditions
- Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- John Lenehan
- Target Recruit Count
- 20
- Registration Number
- NCT06393400
- Locations
- 🇨🇦
Verspeeten Family Cancer Centre (formerly known as the London Regional Cancer Program) London Health Sciences Centre, London, Ontario, Canada
News
No news found